Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02268500 · ClinicalTrials.gov registry record · Phase 4

VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)

A Phase 4 study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
Phase 4
Development phase
48
Enrollment target

NCT02268500: Completed Phase 4 study, sponsored by University of Wisconsin, Madison.

NCT02268500 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 48 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02268500, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
Phase 4
Development phase
48 participants
Enrollment target

Study Summary

A multi-center, prospective, randomized, open-label blinded-endpoint trial in patients with heart failure will be conducted; 20 will be assigned to the standard dose vaccine dose and 20 patients to high dose influenza vaccine. Post-vaccine antibody measurements will be assessed, as well as tolerability differences between groups.

Interventions

  • BIOLOGICAL Influenza vaccine

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2014-09
Est. Completion 2016-05
Phase Phase 4
University of Wisconsin, Madison

1,039 total trials

What the finished NCT02268500 record still lists

NCT02268500 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which Influenza vaccine is the first listed.

NCT02268500 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02268500 about?

NCT02268500 is a clinical study titled "VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)". A multi-center, prospective, randomized, open-label blinded-endpoint trial in patients with heart failure will be conducted; 20 will be assigned to the standard dose vaccine dose and 20 patients to high dose influenza vaccine. Post-vaccine antibody measurements will be assessed, as well as tolerabil...

What is the current status of trial NCT02268500?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2014-09. Estimated completion is 2016-05.

What interventions are being tested in trial NCT02268500?

The interventions under investigation include: Influenza vaccine (BIOLOGICAL).

Who is sponsoring clinical trial NCT02268500?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02268500's enrollment target sits among peer trials

48 1331st of 2000 higher than 653 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02268500, the US trial registry maintained by the National Library of Medicine. NCT02268500 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.